About En Carta Diagnostics
En Carta Diagnostics develops molecular diagnostic technologies that enable the detection of DNA and RNA pathogens at the point of care.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Seed
Global Headquarters
Paris, France
Tracked Since
Oct 2, 2026
Web & Domain Identity
Official Website
encarta.bio
Domain Registered Date
Apr 18, 2020
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Seed announced
- Capital Raise
Raised $1,630,000 · Pre-Seed
startupintros.com
- Milestone
X account created (@encartabio)
12 followers
- Milestone
Website domain registered
encarta.bio
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for En Carta Diagnostics.
Funding History
Seed
· Jul 10, 2026
Undisclosed
Pre-Seed
· May 22, 2024
$1,630,000 startupintros.com
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026